Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Radhika, Parimkayala
NCT04707196: A Study of Abemaciclib in Indian Women With Advanced Breast Cancer	Completed	4	200	RoW	Abemaciclib, LY2835219, Nonsteroidal Aromatase Inhibitor (NSAI), Fulvestrant	Eli Lilly and Company	Breast Neoplasms, Neoplasm Metastasis	01/23	01/23